Navigation Links
Immunoglobulin in Biological Technology

China Biologic Products Announces Strong 2008 Results

... increased by 29.7%. The Company's approved human immunoglobulin for intravenous injection product ... The Company's approved human hepatitis B immunoglobulin product represented 6.9% of revenues in 2008, as ... is used mainly to increase blood volume while immunoglobulin is used for disease prevention and treatment. ...

International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"

... of multiple myeloma (MM) and related disorders. immunoglobulin free light chains (FLC) in serum are an ... bone marrow biopsies; - for some intact immunoglobulin MM patients in remission, relapse is ... The underlying bone marrow disorder/monoclonal immunoglobulin producing disorder is known by many different ...

China Biologic Products Reports Record Third Quarter 2007 Results

... with higher profit margins. Human albumin, Human immunoglobulin for Intravenous Injection and Human Rabies immunoglobulin contributed 61.9%, 11.1% and 15.2% to the ... is used mainly to increase blood volume while immunoglobulin is used for disease prevention and treatment. ...

OMT announces a breakthrough in the development of a novel human antibody platform

... Inc. to knockout a gene encoding rat immunoglobulin. The mutations in rat immunoglobulin caused no off-target effects in other genes, and offspring of the ... to create a knockout, OMT used a new ZFN-mediated technique to generate immunoglobulin knockout rats. ZFNs are engineered proteins that induce double-strand ...

China Biologic Products Receives $5.3 Million Order from Largest Biopharmaceutical Distributor in India

... under the Company's own brand. The order for China Biologic's Human immunoglobulin (ph4) for IV Injection (IVIG) 5g/100ml product will be delivered to the ... statements," including statements regarding: the significance of the human immunoglobulin product order to be shipped to India and its impact on the Company's own ...

China Biologic Products Completes Acquisition of 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.

... Immunoglobulin, Human Hepatitis B Immunoglobulin, Human Tetanus immunoglobulin and Human Rabies Immune Globulin. Based on management's analysis of NICPBP ... human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. ...

China Biologic Products Completes Acquisition of 35% Interest in Xi'an Huitian Blood Products Co., Ltd.

... plasma-based products including Human Albumin, Human Immunoglobulin, Human immunoglobulin for Intravenous Injection, and Human Hepatitis B Immunoglobulin. ... human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. ...

Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations

... These proteins include albumin, clotting factors, and intravenous immunoglobulin (IVIG). Source plasma is collected by plasmapheresis and intended for ... production and sale of high quality, human proteins, including intravenous immunoglobulin (IVIG). From its foundation in 1983, the Swiss-based company has grown to ...

China Biologic Products Reports Strong Third Quarter 2008 Results

... in the sales volume of our human tetanus immunoglobulin and human rabies immunoglobulin products, due primarily to the availability of these products in ... Plasma-based Human Albumin is used mainly to increase blood volume while immunoglobulin is used for disease prevention and treatment. Safe Harbor Statement ...

Octapharma USA Retains Yankee Public Relations as its Agency of Record

... sale of high quality, virus safe plasma derivatives, including intravenous immunoglobulin (IVIG). In the U.S., Octapharma's IVIG product, octagam®, is used to ... sale of high quality, virus safe plasma derivatives, including intravenous immunoglobulin (IVIG). From its foundation in 1983, the Swiss-based company has grown to ...

Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimer's Disease

... Double-Blind, Placebo-Controlled, Phase II Clinical Trial of Intravenous immunoglobulin (IVIG) for Treatment of Alzheimer's Disease" - will discuss the evaluation ... moderate stage Alzheimer's disease. The oral presentation, "Intravenous immunoglobulin Increases Brain Glucose Metabolism in Alzheimer Disease," will also be ...

Proteolix's Carfilzomib Receives Orphan Drug Designation for Treatment of Multiple Myeloma

... out of control, producing large amounts of a protein called monoclonal immunoglobulin M. WM can result in enlargement of the liver and spleen due to anemia and large amounts of immunoglobulin M can lead to hyperviscosity syndrome, in which the blood becomes ...

Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit

... its pipeline of new plasma-based products including IVIG, a polyvalent immunoglobulin in Phase III and Civacir(R) in Phase IIb for the prevention of hepatitis C ... is currently working to develop additional products including a polyvalent immunoglobulin (IVIG, Phase III) and Civacir(R) (Phase IIb), for the prevention of ...

The Leukemia & Lymphoma Society and The International Waldenstrom's Macroglobulinemia Foundation Partner to Develop Cell Lines to Advance Research

... occurs as low-grade B-cell non-Hodgkin lymphoma, characterized by B-lymphocytes in the bone marrow, and an abnormal level of the protein monoclonal immunoglobulin M (IgM). Though the disease is slow-growing, a curative treatment has yet to be developed. Cell lines are invaluable in understanding the genetics ...

Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus

... slow the frequency of the virus in the environment." Dr. Nash continued, "When blockage of the attachment of the virus is the objective, the immunoglobulin package is supplied to humans prior to exposure or immediately after an outbreak. The substantial prevention of viruses in the nasal pharyngeal ...

China Biologic Products Announces Strong First Quarter 2009 Results

... same period a year ago. Sales of human albumin products increased by 171.1% while the average selling price increased by 3.5%. The Company's human immunoglobulin for intravenous injection product represented 25.4% of revenues in the first quarter of 2009, as compared to 21.1% in the first quarter of 2008; its ...

Mach One Closes on Acquisition of Biopharmaceutical Design & Engineering Firm

... long-term health and longevity benefits for disease-threatened animals of large commercial operations. Mach One provides broad spectrum immunoglobulin and nutraceutical products that offer a new level of cost effectiveness, improved health and ease of treatment--with an initial focus on the dairy ...

China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. Safe Harbor Statement This release may contain certain ...

China Biologic Products Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. Safe Harbor Statement This release may contain certain ...

Mach One Executes Definitive Agreement to Acquire Biopharmaceutical Design & Engineering Firm

... -- positive, long-term health and longevity benefits for disease-threatened animals of large commercial operations. Mach One provides broad spectrum immunoglobulin and nutraceutical products that offer a new level of cost effectiveness, improved health and ease of treatment -- with an initial focus on the dairy ...

Mach One Corporation Signs Definitive Agreement to Acquire Ceres Organic Harvest, Inc.

... health and longevity benefits for disease-threatened animals of large commercial operations. Mach One provides colostrum replacement, broad spectrum immunoglobulin and Nutraceutical products that offer a new level of cost effectiveness, improved health and ease of treatment--with an initial focus on the dairy ...

China Biologic Products Enters into Short-Term Loan Agreement

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. Safe Harbor Statement This release may contain certain ...

Russia Chooses Inactivated Polio Vaccine from Sanofi Pasteur for Primary Immunization of all Infants

... new inactivated vaccine against tick-born encephalitis was developed by the Institute. Now scientists are working on creation of human gamma immunoglobulin by new hybrid technology. Vaccines against rabies and hepatitis A were also developed in research laboratories of M.P. Chumakov Institute and other ...

China Biologic Products Announces Third Quarter 2008 Results Conference Call

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases. For more information, please contact: Company Contact: Mr. Y. Tristan Kuo ...

China Biologic Products Enters Into Agreement to Acquire 90% Controlling Interest in Chongqing Dalin Biologic Technologies Co., Ltd.

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. Safe Harbor Statement This release may contain certain "forward-looking ...

Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice

... Director of Process Development from Enobia Pharma will discuss the challenges in engineering the fusion molecule ENB-0040 consisting of TSNALP, an immunoglobulin Fc domain, and an anionic peptide used to target the enzyme to bone at the upcoming IBC 2008 Bioprocessing International Conference, Sept. 23-26, ...

Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents

... services. Biotest AG is a global healthcare company focused on test systems for transfusion and transplant diagnostics as well as clinical immunoglobulin preparations, blood coagulation factors, and environment monitoring. Biotest AG introduced the first test serum for Anti-D -- used to determine the ...

China Biologic Products Reports Second Quarter 2008 Results

... products to hospitals and other health care facilities in China. Plasma-based Human Albumin is used mainly to increase blood volume while immunoglobulin is used for disease prevention and treatment. Safe Harbor Statement This release may contain certain "forward-looking statements" relating to the ...

China Biologic Products Establishes Governance and Nominating Committee and Compensation Committee

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases. Safe Harbor Statement This release may contain certain ''forward-looking ...

China Biologic Products Announces Second Quarter 2008 Results Conference Call

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases. For more information, please contact: Company Contact: Mr. Y. Tristan Kuo ...

China Biologic Products Honored with the Advanced Technology Certification for Foreign-Funded Enterprises

... to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases. Safe Harbor Statement This release may contain certain "forward-looking ...

ProMetic Further Confirms Performance of Prion Capture Resin at the Recovery of Biological Products Conference

... specific proteins such as 25% albumin and 3% immunoglobulin solutions without affecting the concentration of the proteins. Plasma-derived albumin and immunoglobulin proteins are commonly used as therapeutics. Furthermore, proteins such as albumin are also regularly used as non-active stabilizing ingredients in ...

China Biologic Products Reports First Quarter 2008 Results

... products to hospitals and other health care facilities in China. Plasma-based Human Albumin is used mainly to increase blood volume while immunoglobulin is used for disease prevention and treatment. Safe Harbor Statement This release contains certain "forward-looking statements" relating to the ...

China Biologic Products Announces First Quarter 2008 Results Conference Call

... products to hospitals and other health care facilities in China. Plasma-based Human Albumin is used mainly to increase blood volume while immunoglobulin is used for disease prevention and treatment. For more information please contact: Company Contact: Mr. Stanley Wong CEO President China ...

CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies

... administered as replacement therapy in order to increase the antibody levels in patients with immune deficiencies. Privigen(R) is an immunoglobulin (Ig) preparation designed to be administered via intravenous infusion. What sets it apart from other intravenous Ig preparations is that it is ...

China Biologic Products Gains Financial Support from Shandong Provincial Government on the Improvement of Production Facilities

... biopharmaceutical products to hospitals and other health care facilities in China. The Company's principal products are human albumin and immunoglobulin products that are used mainly to increase blood volume and for disease prevention and treatment. Safe Harbor Statement This press release may ...

Biotest Pharmaceuticals Corporation Announces Management Team

... used in the prevention of hepatitis B. Biotest Pharmaceuticals also is currently working to develop additional products including a polyvalent immunoglobulin (IVIG, Phase III) and Civacir(R) (Phase IIb), for the prevention of hepatitis C in liver transplant patients. Biotest Pharmaceuticals was formed in ...

Bruker Announces Availability of New HUPO World Congress Proteomics Posters on Web Site

... T345 -- Automated LC-MALDI Analysis of Glycopeptides from Glycoprotein Digests using DHB as Matrix Poster T348 -- Glycosylation Profiling of immunoglobulin G (IgG) Subclasses Poster T384 Metabolomics -- Detailed Investigation of the Fragmentation of aminopyridinyl-imidazole based MAPKinase ...

Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe

... the source of numerous proteins used for drug development and therapeutic purposes. These proteins include albumin, clotting factors, and intravenous immunoglobulin (IVIG). Octapharma, also a Swiss-based company, is an independent plasma fractionation specialist. One of the top five global plasma ...

Baxter to Launch GARDian(TM), a Groundbreaking Initiative That Helps Provide Continued Access to GAMMAGARD for Current Patients

... and GAMMAGARD S/D. They include: -- GAMMAssist -- An innovative program that allows eligible users of GAMMAGARD to continue to receive their immunoglobulin therapy in the event of a lapse in insurance. -- Low IgA/Brand Intolerance Program -- A program providing patient access to GAMMAGARD S/D ...
Other Contents
(Date:8/22/2014)... , August 22, 2014 ... ) has announced the addition of ... 2014-2018"  report to their offering.  ... ,Biometrics is a technology that helps ... on their physical or behavioral features. ...
(Date:8/22/2014)... RIVERSIDE, Calif. Thomson Reuters , a leading ... five researchers at the University of California, Riverside in ... brightest minds of our times." , To generate the ... (2002-2012) to identify researchers whose published work has had ... included among some 3,200 individuals who published the greatest ...
(Date:8/22/2014)... the 29th Annual International Papillomavirus Conference shows that ... combats three types of human papillomavirus, including the ... cancer. , When tested in several cultured human ... HPV-18 and HPV-11 cells, according to Louise T. ... the findings at the Seattle conference. The National ...
Breaking Biology News(10 mins):Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 2Biometrics Market in North America 2014-2018: Key Vendors are 3M Cogent, Cross Match, NEC and Safran SA 35 UC Riverside scientists among world's most influential scientific minds 2
(Date:8/22/2014)... time an oncogenic somatic mutation at amino acid 918 ... identified in small cell lung cancer (SCLC) tumors and ... produced increased intracellular signaling and cell growth. , SCLC ... 15% of all lung cancers and is strongly associated ... has been extensively examined for genomic alterations and targeted ...
(Date:8/22/2014)... Paying tuition and other related educational ... year for four nurse educators pursuing advanced degrees, thanks ... Nursing Foundation for Nursing Education . This year’s recipients ... more than in 2013, thanks to these named NLN ... Isaac Marcil Endowment Funds, both donated by Kathy Mershon; ...
(Date:8/22/2014)... 22, 2014 Testosterone treatment lawsuits ... U.S. courts on behalf of men who allegedly ... of prescription low testosterone therapies, Bernstein Liebhard LLP ... was filed against Pfizer Inc. on July 31st ... heart issues due to his use of Depo-Testosterone. ...
(Date:8/22/2014)... Hudson County, NJ (PRWEB) August 22, 2014 ... that a leading specialist in Internal Medicine, Geriatrics, ... joined the network, CarePoint Health Medical Group. Their ... of highly skilled and experienced physicians comprise CarePoint ... doctors and practices in Hudson County, representing a ...
(Date:8/22/2014)... News) -- Back-to-school time provides an opportunity for parents ... family schedules, an expert suggests. "Forget New Year,s ... also be the start of a new fitness and ... kinesiology at the University of the Sciences in Philadelphia, ... extracurricular activities likely to build up, "it,s important for ...
Breaking Medicine News(10 mins):Health News:Novel oncogenic RET mutation found in small cell lung cancer 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 2Health News:NLN Foundation for Nursing Education Announces 2014 Faculty Scholarship Awards 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Dr. Reisner Joins CarePoint Health Medical Group 2Health News:With Kids in School, Parents Can Work Out 2
Other TagsOther Tags